CHSS Advice Line
No one should have to recover alone. We’re here to support you with our services, resources and health information.
Resources Hub
Download and order a range of resources to help you manage your condition.
Scotland’s Stories
Read the inspiring stories of the amazing people who are living life to the full with a long-term health condition.
Get free, confidential advice and support from our Advice Line practitioners. No question is too big or too small.
Advice Line
Every day people in Scotland are leaving hospital feeling scared and alone. But you can help us change this.
Fundraising Events
Join Scotland’s Fundraising Heroes by getting involved with one of our exciting events or challenges!
Visit our charity shops
Use our Store Finder to find your local shop or boutique and pop in to see us today.
You can make sure stroke survivors in Scotland like Tim get the support they need after returning home from hospital.
Donate
We are Scotland’s largest health charity working to help people with chest, heart and stroke conditions live life to the full.
Social Media – @chsscotland
Incredible impact
Find out about the incredible impact your support is having and the amazing things you’re helping to achieve.
Search our current job opportunities to find a new role that’s rewarding, exciting and allows you to make a real difference every day.
Work With Us
Type: Heart
Grant holder: Dr Paul Welsh, Dr Preiss, Professors Woodward, Chalmers and Sattar; Cardiovascular Research Centre, University of Glasgow
Amount Awarded: £77,630 over two years
Year: 2013 - Finished
Cutting-edge technology is being harnessed to give a more detailed analysis of the chemical make-up of blood samples than has yet been possible. The research team has developed the ability to measure the levels of more than 100 different components in blood, covering a broad range of fats and sugars. The researchers will test the new technology’s ability to predict heart attacks, thereby improving drug prescription and prevention. This new technology is being applied in a major international trial of diabetes patients, although this will be of particular interest in Scotland where rising diabetes rates threaten to reverse current declining heart attack trends.